Andrew Baum, Pfizer's chief strategy and innovation officer, talked Thursday about the pharmaceutical company's drug ...

Here are three reasons why Pfizer could prove to be a steal of a deal this year. Buying quality stocks at decent valuations ...

Companies with a long history of paying dividends and consistently hiking them remain appealing to income-focused investors.

Pfizer (NYSE:PFE – Get Free Report)‘s stock had its “buy” rating restated by research analysts at Guggenheim in a research ...

Shares of Pfizer Inc. (NYSE:PFE – Get Free Report) have received a consensus rating of “Moderate Buy” from the seventeen ...

The drugmaker has revamped how it packages, promotes and sells certain medicines in an effort to overcome a postpandemic ...

Pfizer Inc. raised about £2.55 billion ($3.3 billion) through the sale of its remaining 7.3% stake in Haleon Plc, culminating ...

Pfizer (PFE) stock in focus as the company sells its entire 7.3% stake in Haleon (HLN) for $3.24B. Read more here.

VOV.VN - Pfizer Vietnam Company Limited (Pfizer VN) and Vietnam Vaccine Joint Stock Company (VNVC) signed a Memorandum of ...

And while many stocks trade at cheap valuations because they are highly risky, that isn't the case with Pfizer. There is some uncertainty about the company's growth prospects, especially as patent ...

Pfizer reportedly offered about 618 million shares through a placement with investors, according to a Wednesday statement.